Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Business-Ticker: Hapag-Lloyd kostet blockierte Meerenge täglich Millionen (FAZ) +++ BROWN-FORMAN B Aktie -4,42%

Foren & Soziale Netzwerke zur HIMS & HERS Aktie

 >HIMS & HERS Aktienkurs 
18.1 EUR    +0.6%    (TradegateBSX)
Ask: 18.15 EUR / 500 Stück
Bid: 17.93 EUR / 500 Stück
Tagesumsatz: 25229 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HIMS & HERS Aktie über LYNX handeln
>HIMS & HERS Performance
1 Woche: -10,0%
1 Monat: +34,2%
3 Monate: -38,5%
6 Monate: -61,6%
1 Jahr: -47,0%
laufendes Jahr: -37,7%
>HIMS & HERS Aktie
Name:  HIMS & HERS HEALTH INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4330001060 / A2QMYY
Symbol/ Ticker:  82W (Frankfurt) / HIMS (NYSE)
Kürzel:  FRA:82W, ETR:82W, 82W:GR, NYSE:HIMS
Index:  -
Webseite:  https://www.hims.com/
Profil:  Hims & Hers Health, Inc. is a leading telehealth platform that connects consumers to licensed healthcare professionals for personalized medical care. The company operates a direct-to-consumer model, o..
>Volltext..
Marktkapitalisierung:  4411.14 Mio. EUR
Unternehmenswert:  4873.87 Mio. EUR
Umsatz:  2022.8 Mio. EUR
EBITDA:  151.81 Mio. EUR
Nettogewinn:  110.6 Mio. EUR
Gewinn je Aktie:  0.49 EUR
Schulden:  965.54 Mio. EUR
Liquide Mittel:  196.98 Mio. EUR
Operativer Cashflow:  258.5 Mio. EUR
Bargeldquote:  1.43
Umsatzwachstum:  40.14%
Gewinnwachstum:  -10.23%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.947.193 USD.
Suchwörter:  HIMS & HERS, HIMS AND HERS, HIMS HERS
Letzte Datenerhebung:  26.03.26
>HIMS & HERS Kennzahlen
Aktien/ Unternehmen:
Aktien: 219.56 Mio. St.
Frei handelbar: 94.31%
Rückkaufquote: 1.42%
Mitarbeiter: 2442
Umsatz/Mitarb.: 0.83 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 18.83%
Bewertung:
KGV: 41.92
KGV lG: 51.57
KUV: 2.41
KBV: 9.19
PEG-Ratio: -
EV/EBITDA: 32.1
Rentabilität:
Bruttomarge: 60.86%
Gewinnmarge: 5.47%
Operative Marge: 5.18%
Managementeffizenz:
Gesamtkaprendite: 8.92%
Eigenkaprendite: 25.23%
>HIMS & HERS Peer Group
Gesundheit, Nahrungsergänzungsmittel & Wellnessprodukte, Kosmetik, Körperpflege & Parfüms
 
14.03.26 - 08:39
mixitrader: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 10.0 €
12.03.26 - 10:15
Momentum Baby! - Target 40 USD (Ariva)
 
Ich liebe diese Momente -Randfigur
11.03.26 - 18:51
$HIMS – Short Squeeze Potential Building (TradingView)
 
NYSE:HIMS – The Short Squeeze Setup May Be Starting NYSE:HIMS is starting to show the early signs of a short squeeze, and the tape is getting harder and harder for bears to control. ? The Price Action: Every dip is getting bought. Sellers push it down intraday and buyers immediately step in. That's the exact behavior you see when a stock transitions from pressure to squeeze. ? Why This Could Accelerate: Nearly 40% of the float is short. The NVO conflict overhang is now gone, removing a major uncertainty. Shorts were leaning heavily on that narrative — and it disappeared overnight. ? Fundamental Shift: NYSE:HIMS has also acquired three major global competitors, strengthening its platform. Many people think of it as just a glorified online pharmacy, but that ignores the distribution network and brand capture they've built. The brand recognition alone is massive — “Hims” is almost becoming a verb. ? What That Means: With the overhang gone, the company can now monetize the ecosystem they built
11.03.26 - 16:48
Barclays_PLC: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 24.9574 €
11.03.26 - 16:24
Rebounding straight to 40 USD! (Ariva)
 
Hims & Hers dürfte jetzt kräftig in Richtung alter Höchststände durchstarten – ohne die Last der Klage im Rücken und mit einer neuen Kooperation mit Novo Nordisk!Die Charttechnik spielt auch schon langsam mit. -Randfigur
11.03.26 - 15:45
$HIMS, my estimate is that ~25% of the supply is still short (TradingView)
 
NYSE:HIMS , still holding the full size. Around 40% of the float was short last week. My estimate is that maybe ~15% has been covered so far, which could still leave roughly ~25% of the supply still short and will contribute to this short squeeze.?
09.03.26 - 17:18
Needham___Company_LL: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 26.025 €
08.03.26 - 09:12
PutBeta56: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 25.0 €
04.03.26 - 18:00
Shooter: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: -
02.03.26 - 16:45
XIIIXIII: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 30.0 €
28.02.26 - 05:39
nvestor: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 6.0 €
24.02.26 - 19:03
Citigroup_Inc_: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 11.24395 €
09.02.26 - 17:03
Citigroup_Inc_: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 13.959 €
09.02.26 - 16:00
quelbe60: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: -
09.02.26 - 10:57
ValueFreak: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 24.0 €
09.01.26 - 13:03
HIMS: on the accumulation zone (TradingView)
 
NYSE:HIMS : . On the accumulation zone Demand zone support. Less supply volume at the bottom. HIMS is swinging on range, wait for Smart money been confirmed with Engulfing candle and volume together. . US STOCKS- WALL STREET DREAM- LET'S THE MARKET SPEAK!
31.12.25 - 16:51
$HIMS - RSI+MACD Divergences for Bullish Plays (TradingView)
 
I think that NYSE:HIMS has an upside potential considering there are clear positive divergences in RSI and MACD. These have also been highlighted at various instances in the past where the price rocketed upwards after giving divergences in RSI and MACD; the price, at that point, either consolidated or gave a rough double bottom. Furthermore, the shrinking volumes add some fuel to fire. I think that the upside potential is up to $47 which I have calculated by using an AVWAP (anchored at its all-time high). This also sort of makes this a mean-reversion trade. So, fingers crossed! Hope to see it up now; otherwise, it'll probably fall to $25 which happens to be an extreme low given after making the all-time high.
31.12.25 - 16:39
$HIMS - RSI+MACD Divergences for Bullish Play (TradingView)
 
I think that NYSE:HIMS has an upside potential considering there are clear positive divergences in RSI and MACD. These have also been highlighted at various instances in the past where the price rocketed upwards after giving divergences in RSI and MACD; the price, at that point, either consolidated or gave a rough double bottom. So, fingers crossed! Hope to see it up now; otherwise, it'll fall to $25 and we'll see where it goes.
31.12.25 - 15:42
12/31/25 - $hims - a bite (TradingView)
 
12/31/25 :: VROCKSTAR :: NYSE:HIMS a bite - growing 20% a year - AI winner disty channel for repeat customer/ consumption type - founder led, n=1 type - sub 30x pe - cash generative (even if low SD fcf yields) - LT winner - buy V
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: So wertlos ist keiner, daß er nicht wenigstens als schlechtes Beispiel herhalten könnte. - Markus M. Ronner
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!